Topic: urinary incontinence
A one-off injection of stem cells into the penis has restored erectile function in some men undergoing prostate removal surgery.
The co-development agreement with BioSerenity builds on 18 months of research into connected fabrics and how the device will fit into care pathways.
The financing comes as Axonics closes in on the end of a clinical trial that will set it up to market the device in the U.S.
The takeover will give Laborie control of devices for the treatment of overactive bladder and stress urinary incontinence.
A trial involving more than 700 patients who were implanted with Johnson & Johnson vaginal mesh or tape devices started in Australian federal court.
Roivant has launched yet another new biotech, this time focused on urologic disorders
NeoTract has presented 5-year data from a clinical trial of its UroLift device.
A jury in Philadelphia has awarded $20 million in damages to a plaintiff who claimed that her pelvic mesh implant failed and caused her injury.
Pelvic health player Laborie is boosting its urodynamics stable with an acquisition of Andromeda Medizinische Systems for an undisclosed amount.
Ixaltis has raised €8 million to trial an abandoned Sanofi antidepressant as a treatment for urinary incontinence.